<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 1739   </title>
<shortdesc>WHOLESALE PRESCRIP DRUG DIST</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Terry Link-Carole Pankau, Pamela J. Althoff-Larry K. Bomke, Iris Y. Martinez, Jacqueline Y. Collins and James T. Meeks</sponsors>
<sponsorhead2>House Sponsors</sponsorhead2><altsponsors>(Rep. Eddie Washington)</altsponsors>
</sponsor>
<lastaction>
<statusdate>1/9/2007</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>5 ILCS 140/7</reference><aliasreference>from Ch. 116, par. 207</aliasreference><reference>5 ILCS 80/4.23</reference><aliasreference></aliasreference><reference>225 ILCS 120/1</reference><aliasreference>from Ch. 111, par. 8301-1</aliasreference><reference>225 ILCS 120/10</reference><aliasreference>from Ch. 111, par. 8301-10</aliasreference><reference>225 ILCS 120/15</reference><aliasreference>from Ch. 111, par. 8301-15</aliasreference><reference>225 ILCS 120/20</reference><aliasreference>from Ch. 111, par. 8301-20</aliasreference><reference>225 ILCS 120/25</reference><aliasreference>from Ch. 111, par. 8301-25</aliasreference><reference>225 ILCS 120/25a new</reference><aliasreference></aliasreference><reference>225 ILCS 120/25b new</reference><aliasreference></aliasreference><reference>225 ILCS 120/25c new</reference><aliasreference></aliasreference><reference>225 ILCS 120/25d new</reference><aliasreference></aliasreference><reference>225 ILCS 120/25e new</reference><aliasreference></aliasreference><reference>225 ILCS 120/25f new</reference><aliasreference></aliasreference><reference>225 ILCS 120/50</reference><aliasreference>from Ch. 111, par. 8301-50</aliasreference><reference>225 ILCS 120/55</reference><aliasreference>from Ch. 111, par. 8301-55</aliasreference><reference>225 ILCS 120/170</reference><aliasreference>from Ch. 111, par. 8301-170</aliasreference><SynopsisText>Amends the Freedom of Information Act to exempt the disclosure of certain information provided under the Wholesale Prescription Drug Distribution Protection and Licensing Act of 2005. Amends the Wholesale Drug Distribution Licensing Act. Changes the short title of the Act to the Wholesale Prescription Drug Distribution Protection and Licensing Act of 2005 and amends the Regulatory Sunset Act to reflect that change. Defines "authorized distributor of record", "sales unit", and "verifiable account". Sets forth separate penalties for certain acts concerning prescription drugs. Provides that the Department of Financial and Professional Regulation shall consider any findings of certain criminal background checks, civil litigation checks, and financial background checks in reviewing the qualifications of persons who engage in the wholesale distribution of prescription drugs in the State. Sets forth requirements for licensure application, drug manufacturer information, a surety bond, a designated representative, a pedigree concerning distribution, and due diligence review by wholesale drug purchasers, as they relate to the wholesale distribution of prescription drugs. Provides that the Department shall conduct a physical inspection of each in-State applicant's facility prior to issuing a license, or, for a wholesale distributor with a valid license on the effective date of this amendatory Act, prior to issuing a renewal, with regular periodic inspections conducted thereafter, no more than 3 years following the last inspection (now, any wholesale drug distributor providing adequate documentation of the most recent satisfactory inspection less than 3 years old of the distributor's wholesale drug distribution activities and facilities by certain comparable entities shall be exempt from further inspection for a period of time to be determined by the Department). Provides that the Department shall make publicly available on its website the dates of the first and most recent inspections of each wholesale distributor and the license suspension, revocation, expiration, or other relevant disciplinary action. Makes other changes.</SynopsisText></synopsis>
<actions>
<statusdate>2/25/2005</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Terry Link</action>
<statusdate>2/25/2005</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>2/25/2005</statusdate><chamber>Senate</chamber><action>Referred to Rules</action>
<statusdate>3/2/2005</statusdate><chamber>Senate</chamber><action>Assigned to Executive</action>
<statusdate>3/2/2005</statusdate><chamber>Senate</chamber><action>Added as Chief Co-Sponsor Sen. Carole Pankau</action>
<statusdate>3/10/2005</statusdate><chamber>Senate</chamber><action>Postponed - Executive</action>
<statusdate>3/10/2005</statusdate><chamber>Senate</chamber><action>Added as Co-Sponsor Sen. Pamela J. Althoff</action>
<statusdate>3/10/2005</statusdate><chamber>Senate</chamber><action>Added as Chief Co-Sponsor Sen. Larry K. Bomke</action>
<statusdate>3/11/2005</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Filed with Secretary by Sen. Terry Link</action>
<statusdate>3/11/2005</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Referred to Rules</action>
<statusdate>3/15/2005</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Rules Refers to  Executive</action>
<statusdate>3/17/2005</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Held in Executive</action>
<statusdate>3/17/2005</statusdate><chamber>Senate</chamber><action>Do Pass Executive;  012-000-000</action>
<statusdate>3/17/2005</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 2nd Reading April 6, 2005</action>
<statusdate>3/18/2005</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Rules</action>
<statusdate>4/8/2005</statusdate><chamber>Senate</chamber><action>Added as Co-Sponsor Sen. Iris Y. Martinez</action>
<statusdate>4/8/2005</statusdate><chamber>Senate</chamber><action>Added as Co-Sponsor Sen. Jacqueline Y. Collins</action>
<statusdate>4/8/2005</statusdate><chamber>Senate</chamber><action>Added as Co-Sponsor Sen. James T. Meeks</action>
<statusdate>4/13/2005</statusdate><chamber>Senate</chamber><action>Second Reading</action>
<statusdate>4/13/2005</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 3rd Reading April 14, 2005</action>
<statusdate>4/15/2005</statusdate><chamber>Senate</chamber><action>Third Reading - Passed; 058-000-000</action>
<statusdate>4/15/2005</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)</action>
<statusdate>4/15/2005</statusdate><chamber>House</chamber><action>Arrived in House</action>
<statusdate>4/15/2005</statusdate><chamber>House</chamber><action>Placed on Calendar Order of First Reading</action>
<statusdate>4/15/2005</statusdate><chamber>House</chamber><action>Chief House Sponsor Rep. Eddie Washington</action>
<statusdate>4/15/2005</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>4/15/2005</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>4/27/2005</statusdate><chamber>House</chamber><action>Assigned to Consumer Protection Committee</action>
<statusdate>5/13/2005</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>1/9/2007</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</actions>
</xml>

